Roche Holding AG (ROG) Stock Forecast & Price Target

Compare

6 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

ROG Analyst Ratings

Hold

5 Buy

5 Hold

2 Sell

Based on 12 analysts giving stock ratings to

Roche

Holding AG

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

ROG Stock 12 Month Forecast

Average Price Target

CHF287.27

▲(6.44%Upside)

Based on 12 Wall Street analysts offering 12 month price targets for Roche Holding AG in the last 3 months. The average price target is CHF287.27 with a high forecast of CHF345.00 and a low forecast of CHF220.00. The average price target represents a 6.44% change from the last price of CHF269.90.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"218":"CHF218","250":"CHF250","282":"CHF282","314":"CHF314","346":"CHF346"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":345.001558896,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">CHF345.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":287.2697544096,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">CHF287.27</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":219.9999343776,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">CHF220.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[218,250,282,314,346],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2024","6":"Dec<br/>2024","9":"Mar<br/>2025","12":"Jun<br/>2025","25":"Jun<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,264.7,270.877042992,277.054085984,283.231128976,289.408171968,295.58521496,301.762257952,307.939300944,314.116343936,320.293386928,326.47042992,332.647472912,338.824515904,{"y":345.001558896,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,264.7,266.4361349545846,268.17226990916924,269.90840486375384,271.64453981833844,273.3806747729231,275.1168097275077,276.8529446820923,278.5890796366769,280.32521459126156,282.06134954584616,283.79748450043076,285.5336194550154,{"y":287.2697544096,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,264.7,261.26153341366154,257.8230668273231,254.3846002409846,250.94613365464613,247.50766706830768,244.06920048196923,240.63073389563075,237.1922673092923,233.75380072295383,230.31533413661538,226.87686755027693,223.43840096393845,{"y":219.9999343776,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":223.604,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 9</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":242.093,"date":1719792000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 29, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 13</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":276.65,"date":1722470400000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 25, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 13</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":278.489,"date":1725148800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 27, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 18</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":256.516,"date":1727740800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 16</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":264.357,"date":1730419200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 24, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 17</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":247.998,"date":1733011200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 13</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":247.32,"date":1735689600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 15</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":276.844,"date":1738368000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 19</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":289.621,"date":1740787200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 18</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":292.4,"date":1743465600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 18</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":269.3,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 14</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":264.7,"date":1748736000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 12</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price TargetCHF345.00

Average Price TargetCHF287.27

Lowest Price TargetCHF220.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

TipRanks AITipRanks

Not Ranked

TipRanks

CHF298

Buy

10.41%

Upside

Reiterated

05/31/25

Roche's strong cash flow generation and positive earnings call guidance are significant strengths, offsetting some concerns about profitability and valuation. The technical indicators suggest a cautious approach, but the company's robust dividend yield and strategic growth initiatives support a favorable overall stock score.

Emmanuel PapadakisDeutsche Bank

Deutsche Bank

CHF250

Sell

-7.37%

Downside

Reiterated

06/05/25

Deutsche Bank Keeps Their Sell Rating on Roche Holding AG (RHHVF)

Benjamin Jackson CFAJefferies

Jefferies

CHF270

Hold

0.04%

Upside

Reiterated

06/05/25

Roche Holding AG (RHHVF) Receives a Hold from Jefferies

Matthew WestonUBS

UBS

CHF314

Buy

16.34%

Upside

Reiterated

05/28/25

Roche Holding AG (RHHVF) Receives a Buy from UBS

Richard VosserJ.P. Morgan

J.P. Morgan

CHF220

Sell

-18.49%

Downside

Reiterated

05/28/25

J.P. Morgan Remains a Sell on Roche Holding AG (RHHVF)

Emily FieldBarclays

Barclays

CHF275

Hold

1.89%

Upside

Reiterated

05/28/25

Barclays Sticks to Its Hold Rating for Roche Holding AG (RHHVF)

Justin SmithBernstein

Bernstein

CHF345

Buy

27.83%

Upside

Reiterated

05/21/25

Analysts Are Bullish on Top Healthcare Stocks: Daiichi Sankyo Company (DSKYF), Innovent Biologics (IVBXF)

Luisa HectorBerenberg Bank

Berenberg Bank

CHF290

Hold

7.45%

Upside

Reiterated

05/16/25

Berenberg Bank Reaffirms Their Hold Rating on Roche Holding AG (RHHVF)

Rajesh KumarHSBC

HSBC

CHF338→CHF295

Hold

9.30%

Upside

Downgraded

04/28/25

Roche downgraded to Hold from Buy at HSBCRoche downgraded to Hold from Buy at HSBC

Sarita KapilaMorgan Stanley

Morgan Stanley

CHF312→CHF286

Hold

5.97%

Upside

Reiterated

04/25/25

Roche Holding AG: Mixed Q1'25 Results and Strategic U.S. Investments Justify Hold Rating

Elmar KrausDZ BANK AG

DZ BANK AG

―

Buy

―

Reiterated

04/24/25

Roche Holding AG (RHHVF) Receives a Buy from DZ BANK AG

David EvansKepler Capital

Kepler Capital

CHF315

Buy

16.71%

Upside

Reiterated

04/24/25

Analysts Offer Insights on Healthcare Companies: Roche Holding AG (Other OTC: RHHVF) and VYNE Therapeutics (NASDAQ: VYNE)

Peter VerdultExane BNP Paribas

Exane BNP Paribas

CHF300

Buy

11.15%

Upside

Initiated

04/16/25

BNP Paribas Exane Starts Roche Holding (ROG:SW) (RHHBY) at OutperformBNP Paribas Exane analyst Peter Verdult initiates coverage on Roche Holding (ROG:SW) (OTC: RHHBY) with a Outperform rating and a price target of CHF300.00.

James QuigleyGoldman Sachs

Goldman Sachs

CHF274

Sell

1.52%

Upside

Reiterated

02/10/25

Goldman Sachs Remains a Sell on Roche Holding AG (RHHVF)

Hans EngelErste Group

Erste Group

―

Hold

―

Downgraded

11/05/24

Erste Group Downgrades Roche Holding (ROG:SW) (RHHBY) to HoldErste Group analyst Hans Engel downgraded Roche Holding (ROG:SW) (OTC: RHHBY) from Buy to Hold.

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

TipRanks AITipRanks

Not Ranked

TipRanks

CHF298

Buy

10.41%

Upside

Reiterated

05/31/25

Emmanuel PapadakisDeutsche Bank

Deutsche Bank

CHF250

Sell

-7.37%

Downside

Reiterated

06/05/25

Deutsche Bank Keeps Their Sell Rating on Roche Holding AG (RHHVF)

Benjamin Jackson CFAJefferies

Jefferies

CHF270

Hold

0.04%

Upside

Reiterated

06/05/25

Roche Holding AG (RHHVF) Receives a Hold from Jefferies

Matthew WestonUBS

UBS

CHF314

Buy

16.34%

Upside

Reiterated

05/28/25

Roche Holding AG (RHHVF) Receives a Buy from UBS

Richard VosserJ.P. Morgan

J.P. Morgan

CHF220

Sell

-18.49%

Downside

Reiterated

05/28/25

J.P. Morgan Remains a Sell on Roche Holding AG (RHHVF)

Emily FieldBarclays

Barclays

CHF275

Hold

1.89%

Upside

Reiterated

05/28/25

Barclays Sticks to Its Hold Rating for Roche Holding AG (RHHVF)

Justin SmithBernstein

Bernstein

CHF345

Buy

27.83%

Upside

Reiterated

05/21/25

Analysts Are Bullish on Top Healthcare Stocks: Daiichi Sankyo Company (DSKYF), Innovent Biologics (IVBXF)

Luisa HectorBerenberg Bank

Berenberg Bank

CHF290

Hold

7.45%

Upside

Reiterated

05/16/25

Berenberg Bank Reaffirms Their Hold Rating on Roche Holding AG (RHHVF)

Rajesh KumarHSBC

HSBC

CHF338→CHF295

Hold

9.30%

Upside

Downgraded

04/28/25

Roche downgraded to Hold from Buy at HSBCRoche downgraded to Hold from Buy at HSBC

Sarita KapilaMorgan Stanley

Morgan Stanley

CHF312→CHF286

Hold

5.97%

Upside

Reiterated

04/25/25

Roche Holding AG: Mixed Q1'25 Results and Strategic U.S. Investments Justify Hold Rating

Elmar KrausDZ BANK AG

DZ BANK AG

―

Buy

―

Reiterated

04/24/25

Roche Holding AG (RHHVF) Receives a Buy from DZ BANK AG

David EvansKepler Capital

Kepler Capital

CHF315

Buy

16.71%

Upside

Reiterated

04/24/25

Analysts Offer Insights on Healthcare Companies: Roche Holding AG (Other OTC: RHHVF) and VYNE Therapeutics (NASDAQ: VYNE)

Peter VerdultExane BNP Paribas

Exane BNP Paribas

CHF300

Buy

11.15%

Upside

Initiated

04/16/25

James QuigleyGoldman Sachs

Goldman Sachs

CHF274

Sell

1.52%

Upside

Reiterated

02/10/25

Goldman Sachs Remains a Sell on Roche Holding AG (RHHVF)

Hans EngelErste Group

Erste Group

―

Hold

―

Downgraded

11/05/24

Erste Group Downgrades Roche Holding (ROG:SW) (RHHBY) to HoldErste Group analyst Hans Engel downgraded Roche Holding (ROG:SW) (OTC: RHHBY) from Buy to Hold.

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Roche Holding AG

1 Month

xxx

Success Rate

31/56 ratings generated profit

Average Return

+0.92%

reiterated a xxx

rating 13 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 55.36% of your transactions generating a profit, with an average return of +0.92% per trade.

3 Months

xxx

Success Rate

32/48 ratings generated profit

Average Return

+1.32%

reiterated a xxx

rating 21 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +1.32% per trade.

1 Year

Richard VosserJ.P. Morgan

Success Rate

27/48 ratings generated profit

Average Return

+1.31%

reiterated a sell rating 21 days ago

Copying Richard Vosser's trades and holding each position for 1 Year would result in 56.25% of your transactions generating a profit, with an average return of +1.31% per trade.

2 Years

xxx

Success Rate

32/56 ratings generated profit

Average Return

+4.69%

reiterated a xxx

rating 13 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 57.14% of your transactions generating a profit, with an average return of +4.69% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ROG Analyst Recommendation Trends

Rating

Feb 25

Mar 25

Apr 25

May 25

Jun 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, ROG has received 12 Buy Ratings, 11 Hold Ratings, and 12 Sell Ratings. ROG average Analyst price target in the past 3 months is 287.27.

Each month's total comprises the sum of three months' worth of ratings.

ROG Financial Forecast

ROG Earnings Forecast

Next quarter’s earnings estimate for ROG is CHF10.53 with a range of CHF10.13 to CHF10.93. The previous quarter’s EPS was CHF8.57. ROG beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.03% of the time in the same period. In the last calendar year ROG has Outperformed its overall industry.

ROG Sales Forecast

Next quarter’s sales forecast for ROG is CHF15.97B with a range of CHF15.95B to CHF15.99B. The previous quarter’s sales results were CHF30.65B. ROG beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 47.56% of the time in the same period. In the last calendar year ROG has Outperformed its overall industry.

ROG Stock Forecast FAQ

What is CH:ROG’s average 12-month price target, according to analysts?

Based on analyst ratings, Roche Holding’s 12-month average price target is 287.27.

What is CH:ROG’s upside potential, based on the analysts’ average price target?

Roche Holding has 6.44% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Roche Holding a Buy, Sell or Hold?

Roche Holding has a consensus rating of Hold, which is based on 5 buy ratings, 5 hold ratings and 2 sell ratings.

What is Roche Holding’s share price target?

The average share price target for Roche Holding is 287.27. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is CHF345.00 ,and the lowest forecast is CHF220.00. The average share price target represents 6.44% Increase from the current price of CHF269.9.

What do analysts say about Roche Holding?

Roche Holding’s analyst rating consensus is a Hold. This is based on the ratings of 12 Wall Streets Analysts.

How can I buy shares of Roche Holding?

To buy shares of CH:ROG, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Roche Holding AG (ROG) Stock Forecast & Price Target

ROG Analyst Ratings

ROG Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Roche Holding AG

ROG Analyst Recommendation Trends

ROG Financial Forecast

ROG Earnings Forecast

ROG Sales Forecast

ROG Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts